SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.19-1.4%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (645)2/17/2000 3:42:00 PM
From: Harold Engstrom  Read Replies (2) of 52153
 
I read that Eisinger article and pretty much viewed it in the same light as TSC articles on SEPR over the past year - not accurate. Guess Eisinger could shake TSC methodologies when coming over to WSJ. ELN has done well over the past couple of weeks (what hasn't?), but my attraction is based on its growth rate, earnings, good fundementals and seemingly good vision. It seems to have a limited downside and there aren't too many stocks like that around right now.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News